AR019785A1 - Pestivirus no diseminantes - Google Patents

Pestivirus no diseminantes

Info

Publication number
AR019785A1
AR019785A1 ARP990105837A ARP990105837A AR019785A1 AR 019785 A1 AR019785 A1 AR 019785A1 AR P990105837 A ARP990105837 A AR P990105837A AR P990105837 A ARP990105837 A AR P990105837A AR 019785 A1 AR019785 A1 AR 019785A1
Authority
AR
Argentina
Prior art keywords
pestivirus
nucleic acid
immune response
particles
type
Prior art date
Application number
ARP990105837A
Other languages
English (en)
Original Assignee
Stichting Dienst Landbouwkundi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8239955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR019785(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stichting Dienst Landbouwkundi filed Critical Stichting Dienst Landbouwkundi
Publication of AR019785A1 publication Critical patent/AR019785A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24323—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24341—Use of virus, viral particle or viral elements as a vector
    • C12N2770/24343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente se relaciona con vacunas utilizadas en la erradicacion o control de infecciones pestivirales, en particular aquellas utilizadas en cerdos orumiantes. La presente proporciona ácido nucleico, partículas de tipo pestivirus y una vacuna de pestivirus que comprende dicho ácido nucleico o partículas,que es capaz de producir una respuesta inmune apropiada sin tener la capacidad de diseminarse a través de todo el animal vacunado, evitando así lasconsecuencias negativas de la diseminacion viral. Con preferencia dicha respuesta inmune permite la discriminacion serologica entre animales vacunados yanimales infectados con pestivirus de tipo salvaje.
ARP990105837A 1999-03-08 1999-11-17 Pestivirus no diseminantes AR019785A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200669A EP1035205A1 (en) 1999-03-08 1999-03-08 Non-spreading pestivirus

Publications (1)

Publication Number Publication Date
AR019785A1 true AR019785A1 (es) 2002-03-13

Family

ID=8239955

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105837A AR019785A1 (es) 1999-03-08 1999-11-17 Pestivirus no diseminantes

Country Status (10)

Country Link
US (2) US6923969B2 (es)
EP (2) EP1035205A1 (es)
AR (1) AR019785A1 (es)
AT (1) ATE341629T1 (es)
AU (1) AU3198300A (es)
CA (1) CA2366056C (es)
DE (1) DE60031098T3 (es)
DK (1) DK1161537T4 (es)
ES (1) ES2273669T5 (es)
WO (1) WO2000053766A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1035205A1 (en) 1999-03-08 2000-09-13 Stichting Dienst Landbouwkundig Onderzoek Non-spreading pestivirus
WO2004016794A1 (en) * 2002-08-13 2004-02-26 Akzo Nobel N.V. Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines
WO2004092386A2 (en) * 2003-04-11 2004-10-28 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Inducing a t cell response with recombinant pestivirus replicons or recombinant pestivirus replicon-transfected dendritic cells
DK1699919T3 (en) 2003-12-24 2017-03-20 De Staat Der Nederlanden Vertegenwoordigd Door De Mini Van Volksgezondheid Welzijn En Sport RESPIRATORY SYNCYTIAL VIRUS WITH A GENOMIC DEFICIENCY COMPLETED IN TRANS
AR062917A1 (es) 2006-09-22 2008-12-17 Intervet Int Bv Nuevo mutante de pestivirus para uso en una vacuna.
EP2130912A1 (en) 2008-06-04 2009-12-09 Institut für Viruskrankeiten und Immunprophylaxe Pestivirus replicons providing an RNA-based viral vector system
EP2202298A1 (en) 2008-12-23 2010-06-30 Stichting Dienst Landbouwkundig Onderzoek Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA901719B (en) 1989-03-19 1991-01-30 Akzo Nv Hog cholera virus vaccine and diagnostics
US5514634A (en) 1991-11-06 1996-05-07 Mobil Oil Corporation High activity polyethylene catalysts
EP0702085B2 (en) * 1994-07-18 2010-01-13 Conzelmann, Karl-Klaus, Prof. Dr. Recombinant infectious non-segmented negative strand RNA virus
WO1996019498A2 (en) 1994-12-20 1996-06-27 Akzo Nobel N.V. T cell stimulating protein of pestivirus
CA2223125A1 (en) 1995-02-17 1996-08-22 Stichting Instituut Voor Dierhouderij En Diergezondheid Production of biologically active recombinant bovine follicle stimulating hormone (recbfsh) in the baculovirus expression system
US5792462A (en) * 1995-05-23 1998-08-11 University Of North Carolina At Chapel Hill Alphavirus RNA replicon systems
US5849388A (en) 1996-02-02 1998-12-15 Imation Corp. Article, apparatus and method for cooling a thermally processed material
WO1999028487A1 (en) * 1997-11-28 1999-06-10 The Crown In The Right Of The Queensland Department Of Health Flavivirus expression and delivery system
EP0924298A1 (en) 1997-12-18 1999-06-23 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Protein expression in baculovirus vector expression systems
US7179473B2 (en) * 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US6168942B1 (en) * 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
AU771774B2 (en) * 1998-12-07 2004-04-01 U.S. Medical Research Institute Of Infectious Diseases Live attenuated Venezuelan equine encephalitis vaccine
AU2220800A (en) * 1998-12-31 2000-07-31 Chiron Corporation Compositions and methods for packaging of alphavirus vectors
EP1035205A1 (en) * 1999-03-08 2000-09-13 Stichting Dienst Landbouwkundig Onderzoek Non-spreading pestivirus

Also Published As

Publication number Publication date
DK1161537T3 (da) 2007-02-05
EP1161537B2 (en) 2010-07-21
CA2366056C (en) 2011-11-01
US6923969B2 (en) 2005-08-02
DE60031098T2 (de) 2007-05-16
ES2273669T3 (es) 2007-05-16
EP1161537A1 (en) 2001-12-12
US20020106641A1 (en) 2002-08-08
US7521058B2 (en) 2009-04-21
ATE341629T1 (de) 2006-10-15
EP1035205A1 (en) 2000-09-13
DK1161537T4 (da) 2010-11-08
AU3198300A (en) 2000-09-28
EP1161537B1 (en) 2006-10-04
US20050220813A1 (en) 2005-10-06
DE60031098T3 (de) 2011-03-31
WO2000053766A1 (en) 2000-09-14
CA2366056A1 (en) 2000-09-14
ES2273669T5 (es) 2011-01-03
DE60031098D1 (de) 2006-11-16

Similar Documents

Publication Publication Date Title
NO20023829D0 (no) Proteosom influensavaksine
ATE549032T1 (de) Adjuvanzverbindungen zur verbesserung von immunreaktionen auf polynukleotid-basierten impfstoffen
PT777490E (pt) Enterotoxina mutante eficaz como adjuvante oral nao toxico
DE60226911D1 (de) Entwicklung einer Vakzine zur Prävention von Infektionen mit Filovirus bei Primaten
ATE526994T1 (de) Mtb32a antigen aus mycobakterium tuberculosis mit inaktivierter protease aktivität und fusionsproteine die das antigen enthalten
FI910497A0 (fi) Nytt virus vid infektioes bursalsjukdom.
AR036125A1 (es) Vacuna de mycoplasma bovis metodos para reducir la neumonia en animales; procedimiento de preparacion de dicha vacuna y kit
ATE517184T1 (de) Hcv ns3/4a kodierende nukleinsäure
AR019785A1 (es) Pestivirus no diseminantes
DK437980A (da) Felin infektioest peritonitis-virum og vacciner fremstillet deraf
ATE310008T1 (de) Immunologische adjuvans verbindungen
WO2002081621A3 (fr) Vaccin contre le virus de la fievre du nil
CO5280138A1 (es) Virus atenuados e inocuos de la diarrea virica bovina para en vacas gestantes
NO20054219D0 (no) Inaktivert Nodavirus-vaksine
DE602004023196D1 (de) Vakzine zusammensetzung zur impfung von hunden gegen infektiöse atemwegserkrankung bei hunden (cird)
ES2063897T5 (es) Vacuna contra el virus del colera porcino y diagnostico.
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
ES2059305T3 (es) Proteina del virus de la seudorrabia.
DE69534280D1 (de) Orale impfstoffe gegen yersinia pestis infektionen
ATE374622T1 (de) Genetische impstoffe mit adjuvans
ATE432943T1 (de) Einschlusskörper als antigene für die orale impfung von tieren gegen csfv
RU2003131029A (ru) Способ диагностики лейкоза крупного рогатого скота
Kaeberle et al. Infectious Bovine Rhinotracheitis Virus Antibody Responses to Vaccines Used in Combination
TH50271A3 (th) เพสทิไวรัสที่ไม่แผ่กระจาย
ES2172482B1 (es) Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania".

Legal Events

Date Code Title Description
FB Suspension of granting procedure